News
& Events
What´s new at Flavine? We´ll keep you updated on any development and news on this page. Feel free to share also our event informations!
New US DMF Filing – Ruxolitinib Phosphate
We are proud to announce the filing of a new US DMF (041214) for Ruxolitinib Phosphate, registered to Flavine. Validated commercial-scale API is now available for immediate use.
Beyond Ruxolitinib Phosphate, we are positioned to collaborate on alternative salt forms, polymorphic crystals, and novel dosage form development programs.
Flavine has partnered with a reputed CDMO to develop and manufacture Ruxolitinib Phosphate API. Flavine can support your filing strategy by utilizing our expertise of serving the generic industry for 50 years.
Ruxolitinib Phosphate is a potent and selective anticancer, inhibitor of Janus kinase‑1 and Janus kinase‑2. As a BCS Class I drug, it is a candidate for BCS bio-waiver in lieu of BE study.
Ruxolitinib Phosphate is indicated for these therapeutic treatments:
- Intermediate or high-risk myelofibrosis (MF)
- Resistant forms of polycythemia vera (PV)
- Acute and chronic graft-vs-host disease (GVHD)
- Topical treatment of atopic dermatitis
- Topical treatment of nonsegmental vitiligo
Contact Flavine for Ruxolitinib Phosphate samples and more information on other salts.
Disclaimer: All products which are covered under current patents are available only for use reasonably related to the development and submission of information to the related Health Authorities to the extent permitted under applicable laws regulating the manufacture, use and sales of Active Pharmaceutical Ingredients and/or their intermediates.
New Development — Ruxolitinib Phosphate API
Approved Ruxolitinib Phosphate finished dosage forms:
- JAKAFI® (oral tablets) by Incyte Corporation
- OPZELURA™ (topical cream) by Incyte Corporation
- JAKAVI® (oral tablets) licensed to Novartis
New Laboratory Facility
New EU Retest & Release Laboratory
In a world where the healthcare revolution is increasingly transforming our lives, Flavine is leading the expansion of sourcing activities for its customers. For more than 50 years, we are thriving to add value to the business of both suppliers and customers by locating and developing quality manufacturers and opening up new markets.
Flavine is excited to announce our new, state of the art, GMP-compliant laboratory facility that offers comprehensive analytical services, QC retest, and release testing of active pharmaceutical ingredients and finished dosage forms. Complementing our full-service QC testing, we also provide robust method development, validation, and transfer of pharmaceutical products and raw materials.
New GMP Sampling Installation:
- Changing room
- Sampling area with laminar air flow and HEPA filtration
- Suitable scales for various package shipment sizes
- Interlocking doors system
- Separate operations for the flow of material and personnel
- Routine environmental monitoring
- Control and monitoring of microbiological quality
- Airlocks and pass-throughs chamber
EcoVadis Gold Medal in 2026
Flavine has been awarded the EcoVadis Gold Medal in 2026, placing us among the top 5% of companies globally. This distinction reflects our structured and ongoing commitment to operating at the highest standards across Environment, Labor & Human Rights, Business Ethics, and Sustainable Procurement. It further demonstrates the robustness of our governance frameworks and our ability to consistently meet stringent sustainability criteria.
This achievement reinforces Flavine’s position as a reliable and responsible partner, dedicated to delivering sustainable value while advancing ethical and compliant business practices across our global operations.
Next Events
CPhI North America
Start Date: June 2, 2026 //End Date: June 4, 2026 // Pennsylvania…
Read MoreEuroPLX — 2026
Start Date: 08 June 2026 // End Date: 09 June 2026…
Read MoreCPhI China
Start Date: June 16, 2026 // End Date: June 18, 2026 // Shanghai…
Read MoreChemOutsourcing
Start Date: September 15, 2026 // End Date: September 17, 2026 // Boston,…
Read MoreCPhI Worldwide
Start Date: October 06, 2026 // End Date: October 08, 2026 // CPHI…
Read MoreCPHI India
Start Date: November 23, 2026 // End Date: November 25, 2026 // CPHI India 2026 //…
Read MoreVeterinary Meeting & Expo
Dates: Saturday, January 16, 2027 — Wednesday, January 20, 2027 Venue:…
Read MoreWestern Veterinary Conference
WVC Vegas 2027Western Veterinary ConferenceDates: TBDVenue: Mandalay Bay Convention Center,…
Read More